Skip to main content

Disclaimer

In the Downloads section, the ‘Prior Submission’ file reflects the most recent measure submission to the former CBE. This file is provided for transparency. For any questions or clarification, please contact the designated measure steward.

Cardiac Tamponade and/or Pericardiocentesis Following Atrial Fibrillation Ablation

CBE ID
2474
Endorsement Status
Endorsement Removed
E&M Committee Rationale/Justification

Steward no longer pursuing endorsement.

1.0 New or Maintenance
Maintenance
1.1 Measure Structure
Single Measure
Previous Endorsement Cycle
Full Year 2014
Is Under Review
No
1.6 Measure Description

Rate of cardiac tamponade and/or pericardiocentesis following atrial fibrillation (AF) ablation.

Measure Specs
General Information
1.7 Measure Type
Outcome
1.3 Electronic Clinical Quality Measure (eCQM)
No
1.8 Level of Analysis
Clinician: Individual
Facility
1.20 Types of Data Sources
Claims Data
1.14 Numerator

The number of patients from the denominator with cardiac tamponade and/or pericardiocentesis occurring within 30 days following atrial fibrillation ablation.

1.15 Denominator

All patients aged 18 years and older with atrial fibrillation ablation performed during the reporting period.

Exclusions

No exclusions.

Most Recent Endorsement Activity
Endorsed Cardiovascular Project 2014-2015
Initial Endorsement
Last Updated
Removal Date
Steward Organization
American College of Cardiology
Steward POC email
[email protected]
Steward Organization Copyright

© 2014 Heart Rhythm Society. All Rights Reserved.

Risk Adjustment
Stratification by risk category/subgroup
Use
Planned Use
Payment Program
Public Reporting
6.1.2 Current or Planned Use(s)
Payment Program
Public Reporting
Use In Federal Program
Medicare Physician Quality Reporting System (PQRS)
Physician Feedback/Quality and Resource Use Reports (QRUR)
Physician Value-Based Payment Modifier (VBM)
Public Comments